Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stinking hellebore extract is a botanical preparation derived from the plant *Helleborus foetidus*. Developed by the Verein für Krebsforschung (Association for Cancer Research), the extract is being investigated for its potential antineoplastic properties. Research focuses on both fermented and unfermented versions of the extract, which have demonstrated in vitro cytotoxic activity against various cancer cell lines. While the exact molecular targets remain undefined, the extract is part of a broader research program into mistletoe and other botanical therapies for oncology. It is currently in the preclinical stage of development, with studies primarily focused on characterizing its cytotoxic profile in vitro.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stinking hellebore extract.